* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download PHL 424 1st SF
Survey
Document related concepts
Magnesium transporter wikipedia , lookup
Protein moonlighting wikipedia , lookup
Ancestral sequence reconstruction wikipedia , lookup
Protein (nutrient) wikipedia , lookup
Western blot wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
Protein adsorption wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Drug discovery wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Two-hybrid screening wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Bottromycin wikipedia , lookup
De novo protein synthesis theory of memory formation wikipedia , lookup
Transcript
PHL 424 Antimicrobials 1st Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212 Email: [email protected] Inhibitors of bacterial protein synthesis, Overview These agents are bacteriostatic, protein-synthesis inhibitors that target the ribosome Examples: Chloramphenicol, macrolides, clindamycin, tetracyclines Reason For Selective Toxicity These antibiotics exert their antimicrobial effects by targeting the bacterial ribosome, which has components that differ structurally from those of the mammalian cytoplasmic ribosome In general, the bacterial ribosome is smaller (70S) than the mammalian ribosome (80S) Bacterial ribosome is composed of 50S and 30S subunits, whereas human ribosome is comprised of 60S and 40S subunits Inhibitors of bacterial protein synthesis, General MOA Chloramphenicol Tetracyclines Θ Θ (P-site) (A-site) Θ Macrolides, clindamycin Inhibitors of bacterial protein synthesis, Chloramphenicol It is an antibiotic produced by Streptomyces venezuelae It is a potent inhibitor of microbial protein synthesis MOA: It binds reversibly to the 50S subunit of the bacterial ribosome and thus inhibits the peptidyl transferase step of protein synthesis {i.e., it inhibits the transpeptidation reaction (1)} ……How? It binds to the 50S ribosomal subunit at the peptidyltransferase site, thus the interaction between peptidyltransferase and its amino acid substrate cannot occur, and peptide bond formation is inhibited It also can inhibit mammalian mitochondrial protein synthesis {mitochondrial ribosomes resemble bacterial ribosomes (both are 70S)} The peptidyltransferase of mammalian mitochondrial ribosomes, but not of cytoplasmic ribosomes, is inhibited by chloramphenicol inhibition of synthesis of proteins of the inner mitochondrial membrane Mammalian erythropoietic cells are particularly sensitive to the drug Much of the toxicity observed with this drug can be attributed to these effects Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Antimicrobial Actions: It is a bacteriostatic broad-spectrum antibiotic that is active against both aerobic and anaerobic G+ve and G-ve organisms It is active also against rickettsiae and mycoplasma Haemophilus influenzae, Neisseria meningitidis and Bordetella pertussis are highly susceptible Strains of S. aureus tend to be less susceptible P. aeruginosa is resistant to even very high concentrations of the drug Resistance: It is usually caused by a plasmid-encoded acetyltransferase that inactivates the drug. Acetylated derivatives of chloramphenicol fail to bind to bacterial ribosomes Resistance also can result from decreased permeability and from ribosomal mutation Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Pharmacokinetics It is readily absorbed from the GIT The parenteral formulation, chloramphenicol succinate, yields free chloramphenicol by hydrolysis, giving blood levels lower than those achieved with orally administered drug After absorption, it is widely distributed in body fluids and readily reaches therapeutic concentrations in CSF Hepatic metabolism to the inactive glucuronide is the major route of elimination. This metabolite and chloramphenicol itself are excreted in the urine. About 50% of chloramphenicol is bound to plasma proteins; such binding is reduced in cirrhotic patients and in neonates Patients with cirrhosis or otherwise impaired hepatic function have decreased metabolic clearance, and dosage should be adjusted in these individuals Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Therapeutic Uses: Because of potential toxicity, bacterial resistance, and the availability of other effective drugs (e.g., cephalosporins), chloramphenicol is almost an obsolete as a systemic drug It may be considered for treatment of serious rickettsial infections in children for whom tetracyclines are contraindicated, i.e., those under 8 years of age It is an alternative to b-lactam antibiotics for treatment of meningococcal meningitis occurring in patients who have major hypersensitivity reactions to penicillin or bacterial meningitis caused by penicillin-resistant strains of pneumococci It is used topically in the treatment of eye infections because of its wide antibacterial spectrum and its penetration of ocular tissues and the aqueous humor Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Side effects: The most important adverse effect of chloramphenicol is on the bone marrow It affects the hematopoietic system in two ways: a dose-related toxicity that presents as anemia, leukopenia, or thrombocytopenia; and an idiosyncratic response manifested by aplastic anemia, leading in many cases to fatal pancytopenia A genetic predisposition is suggested by the occurrence of pancytopenia in identical twins Aplastic anemia accounts for approximately 70% of cases of blood dyscrasias due to chloramphenicol, while hypoplastic anemia, agranulocytosis, and thrombocytopenia make up the remainder Dose-related, reversible erythroid suppression due to an inhibitory action of chloramphenicol on mitochondrial protein synthesis in erythroid precursors, which in turn impairs iron incorporation into heme Nausea and vomiting, unpleasant taste, diarrhea, and perineal irritation may follow the oral administration of chloramphenicol Oral or vaginal candidiasis may occur as a result of alteration of normal microbial flora Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Side effects, cont.d Toxicity for Newborn Infants Newborn infants, especially if premature, lack an effective glucuronic acid conjugation mechanism for the degradation & detoxification of chloramphenicol, with subsequent inadequate renal excretion of unconjugated drug Consequently, when infants are given dosages above 50 mg/kg/d, the drug may accumulate, resulting in a serious illness termed gray baby syndrome, with vomiting, refusal to suck, passage of loose, green stools, cyanosis, ashen-gray color, flaccidity, hypothermia, shock and collapse Death occurs in about 40% of patients within 2 days of initial symptoms. Those who recover usually exhibit no sequelae To avoid this toxic effect, chloramphenicol should be used with caution in infants, and the dosage limited to 50 mg/kg/d or less (during the first week of life) in fullterm infants and 25 mg/kg/d in premature infants Toxic effects have not been observed in the newborns when as much as 1 g of the antibiotic has been given every 2 hours to the mothers during labor Inhibitors of bacterial protein synthesis, Chloramphenicol, contd. Drug interactions: It inhibits hepatic microsomal enzymes that metabolize several drugs such as warfarin Conversely, other drugs may alter the drug elimination. Concurrent administration of phenobarbital or rifampin, which potently induce CYPs, shortens its t1/2 and may result in subtherapeutic drug concentrations Like other bacteriostatic inhibitors of microbial protein synthesis, chloramphenicol can antagonize bactericidal drugs such as penicillins or aminoglycosides